Holdings
Ishara Investments LP
As of Jun 30, 2026, Ishara Investments LP reported 36 positions worth US$130M. Largest: Acadia Pharmaceuticals Inc., Xeris Biopharma Holdings, Inc. and Biomarin Pharmaceutical Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Acadia Pharmaceuticals Inc. | 410K | US$10.4M | +287K | Jun 30, 2026 |
| Xeris Biopharma Holdings, Inc. | 1.23M | US$9.74M | +205K | Jun 30, 2026 |
| Biomarin Pharmaceutical Inc. | 144K | US$8.21M | +61,500 | Jun 30, 2026 |
| Praxis Precision Medicines, Inc. | 22,550 | US$7.55M | no change | Jun 30, 2026 |
| Ultragenyx Pharmaceutical Inc. | 205K | US$6.84M | +30,750 | Jun 30, 2026 |
| Agios Pharmaceuticals, Inc. | 164K | US$6.09M | new | Jun 30, 2026 |
| Insmed Incorporated | 51,250 | US$5.46M | new | Jun 30, 2026 |
| Crinetics Pharmaceuticals, Inc. | 144K | US$5.37M | new | Jun 30, 2026 |
| Zentalis Pharmaceuticals, Inc. | 1.02M | US$4.97M | −205K | Jun 30, 2026 |
| Vaxcyte, Inc. | 82,000 | US$4.77M | +24,600 | Jun 30, 2026 |